The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnostics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1425450

No of Pages : 88

Synopsis

Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.

The global Molecular Diagnostics market was valued at US$ 639.2 million in 2023 and is anticipated to reach US$ 941.9 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics.

Report Scope

The Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List):

  • Agilent Technologies
  • BD
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • Eppendorf
  • PerkinElmer
  • Tecan Group
  • Thermo Fisher Scientific
  • QIAGEN

Segment by Type

  • Real Time- PCR Systems
  • Liquid Handling System
  • NA Extraction System

Segment by Application

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Real Time- PCR Systems
1.2.3 Liquid Handling System
1.2.4 NA Extraction System
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Pharmaceutical and Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Market Perspective (2019-2030)
2.2 Molecular Diagnostics Growth Trends by Region
2.2.1 Global Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Molecular Diagnostics Market Dynamics
2.3.1 Molecular Diagnostics Industry Trends
2.3.2 Molecular Diagnostics Market Drivers
2.3.3 Molecular Diagnostics Market Challenges
2.3.4 Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Players by Revenue
3.1.1 Global Top Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Revenue
3.4 Global Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Revenue in 2023
3.5 Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Breakdown Data by Type
4.1 Global Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 Molecular Diagnostics Breakdown Data by Application
5.1 Global Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Diagnostics Market Size (2019-2030)
6.2 North America Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Market Size (2019-2030)
7.2 Europe Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Molecular Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Molecular Diagnostics Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Introduction
11.2.4 BD Revenue in Molecular Diagnostics Business (2019-2024)
11.2.5 BD Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Molecular Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Molecular Diagnostics Introduction
11.4.4 Danaher Revenue in Molecular Diagnostics Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Detail
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Eppendorf
11.6.1 Eppendorf Company Detail
11.6.2 Eppendorf Business Overview
11.6.3 Eppendorf Molecular Diagnostics Introduction
11.6.4 Eppendorf Revenue in Molecular Diagnostics Business (2019-2024)
11.6.5 Eppendorf Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Detail
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Molecular Diagnostics Introduction
11.7.4 PerkinElmer Revenue in Molecular Diagnostics Business (2019-2024)
11.7.5 PerkinElmer Recent Development
11.8 Tecan Group
11.8.1 Tecan Group Company Detail
11.8.2 Tecan Group Business Overview
11.8.3 Tecan Group Molecular Diagnostics Introduction
11.8.4 Tecan Group Revenue in Molecular Diagnostics Business (2019-2024)
11.8.5 Tecan Group Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Molecular Diagnostics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Molecular Diagnostics Introduction
11.10.4 QIAGEN Revenue in Molecular Diagnostics Business (2019-2024)
11.10.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’